Outbreak spotlights risks from custom-mixed drugs - Article Photos 2/2

An unidentified man carries packages out of New England Compounding in Framingham, Mass., Thursday, Oct. 4, 2012. An outbreak of a rare and deadly form of fungal meningitis that has killed 4 people and sickened another 26 in five states is believed to have been traced back to a steroid manufactured by the New England Compounding Center. Investigators, though, say they are still trying to confirm the source of the infection. (AP Photo/Stephan Savoia)